Vaginitis | Brochures
BD Vaginal Panel Reimbursement and Market Access Toolkit
This toolkit serves as a guide on coding and the appeals process.
Review and share useful Women’s Health brochures here.
Cervical Cancer | Brochures
HPV 31 Patient profile
Tianna* is 35, has normal cytology and HPV 31. If she was your patient, what would you do? Learn how individually identifying HPV 31 can benefit your patients like Tianna.
Vaginitis | Brochures
Get her vaginitis diagnosis right the first time with the BD Vaginal Panel
Learn more about how the BD Vaginal Panel provides a more accurate vaginitis diagnosis as compared to traditional methods.
Vaginitis and STIs: The right treatment begins with the right diagnosis
Learn more about how the BD Vaginal Panel and the BD CTGCTV2 assay can help decrease the number of recurrent visits, incorrect treatments and negative sequelae associated with vaginits and STIs.
Cervical Cancer | Brochures
Identify HPV 31 with BD Onclarity™ HPV Assay
Learn more about the importance of HPV 31 and the BD Onclarity™ HPV Assay with extended genotyping, the only FDA-approved HPV test that individually identifies HPV 31.
Latest resources
Discover our latest articles, webinars, press releases and updates in women's health.
Cervical Cancer | News & Updates
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
Cervical Cancer | News & Updates
ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women
